VEGF-dependent conjunctivalization of the corneal surface

Area of Science:

• Ophthalmology
• Molecular Biology
• Immunology

Background:

• Corneal neovascularization and goblet cell presence are key features of limbal stem cell deficiency.
• Understanding the molecular mechanisms driving these changes is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the mechanisms of corneal neovascularization and goblet cell appearance in a murine model of limbal insufficiency.
• To determine the role of Vascular Endothelial Growth Factor (VEGF) and its receptor Flt-1 (VEGFR1) in these processes.

Main Methods:

• Analysis of spatial and temporal relationships between corneal neovascularization and goblet cell density.
• Immunohistochemical detection and expression analysis of Flt-1 (VEGFR1) using wild-type and transgenic mice.
• Assessment of Flt-1 mRNA and protein in goblet cells and conjunctiva.
• Systemic inhibition of VEGF bioactivity using an adenoviral vector to evaluate its effect on neovascularization and goblet cell appearance.

Main Results:

• Corneal neovascularization preceded goblet cell appearance, with temporal overlap.
• Flt-1 was expressed in the corneal epithelium, goblet cells, leukocytes, and vasculature.
• Systemic inhibition of VEGF bioactivity significantly suppressed both corneal neovascularization and goblet cell density (P < 0.001).

Conclusions:

• VEGF signaling, partly mediated by the Flt-1 receptor, regulates both corneal neovascularization and goblet cell appearance.
• Anti-VEGF therapeutic strategies hold promise for limiting vision loss associated with corneal conjunctivalization.